Muñoz JF, Gade L, Chow NA, et al. Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species. Nat Commun. 2018;9(1):5346. doi:10.1038/s41467-018-07779-6
Publications
Pinhal CM, van den Boom BJG, Santana-Kragelund F, et al. Differential Effects of Deep Brain Stimulation of the Internal Capsule and the Striatum on Excessive Grooming in Sapap3 Mutant Mice. Biol Psychiatry. 2018;84(12):917-925. doi:10.1016/j.biopsych.2018.05.011
Walker MA, Pedamallu CS, Ojesina AI, et al. GATK PathSeq: a customizable computational tool for the discovery and identification of microbial sequences in libraries from eukaryotic hosts. Bioinformatics. 2018;34(24):4287-4289. doi:10.1093/bioinformatics/bty501
Laisk T, Kukuškina V, Palmer D, et al. Large-scale meta-analysis highlights the hypothalamic-pituitary-gonadal axis in the genetic regulation of menstrual cycle length. Hum Mol Genet. 2018;27(24):4323-4332. doi:10.1093/hmg/ddy317
Currall BB, Chen M, Sallari RC, et al. Loss of LDAH associated with prostate cancer and hearing loss. Hum Mol Genet. 2018;27(24):4194-4203. doi:10.1093/hmg/ddy310
An JY, Lin K, Zhu L, et al. Genome-wide de novo risk score implicates promoter variation in autism spectrum disorder. Science. 2018;362(6420). doi:10.1126/science.aat6576
Abascal F, Juan D, Jungreis I, et al. Corrigendum: Loose ends: almost one in five human genes still have unresolved coding status. Nucleic Acids Res. 2018;46(22):12194. doi:10.1093/nar/gky1146
Cardoso MH, Cândido ES, Chan LY, et al. A Computationally Designed Peptide Derived from Escherichia coli as a Potential Drug Template for Antibacterial and Antibiofilm Therapies. ACS Infect Dis. 2018;4(12):1727-1736. doi:10.1021/acsinfecdis.8b00219
Choi SH, Weng LC, Roselli C, et al. Association Between Titin Loss-of-Function Variants and Early-Onset Atrial Fibrillation. JAMA. 2018;320(22):2354-2364. doi:10.1001/jama.2018.18179
Liu S, Marneth AE, Alexe G, et al. The kinases IKBKE and TBK1 regulate MYC-dependent survival pathways through YB-1 in AML and are targets for therapy. Blood Adv. 2018;2(23):3428-3442. doi:10.1182/bloodadvances.2018016733